课题基金 / 基金详情

Establishment of an early diagnostic system for the detection of heart disease-related gene mutations with a novel electrochemical array chip

Establishment of an early diagnostic system for the detection of heart disease-related gene mutations with a novel electrochemical array chip
新型电化学阵列芯片建立心脏病相关基因突变早期诊断系统
批准号:
14570376
负责人:
IKEDA Yasuyuki
金额:
$1.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

IKEDA Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
杂合子LPL缺乏症的受试者(携带者)在合并高胰岛素状态和/或高酒精摄入等刺激肝脏中甘油三酯合成的环境因素时,容易发生轻度高甘油三酯血症(IV型高脂蛋白血症),而携带者在没有环境因素的情况下,则是正常血脂。因此,鉴别杂合LPL基因突变作为早期诊断对于通过让患者改变更健康的生活方式来预防高甘油三酯血症的发展和随后的动脉粥样硬化的发展是重要的。我们的目的是建立和评估与二茂铁萘二亚胺(FND)的电化学杂交检测杂合LPL基因突变。我们开发了用于检测LPL杂合突变的电化学杂交试验,这些杂合突变是LPL基因第818位的G到a过渡(G188E: 818G正常等位基因和818A突变等位基因)和LPL基因第916位-外显子5的G缺失(916G正常等位基因和916G-del突变等位基因)。野生型(Wt)和突变型(Mt)等位基因的区分是基于固定在金电极上的两个探针(Wt探针和Mt探针(13-15 mer)和PCR产物5外显子(350 bp)之间的杂交。用FND作为插层剂,在460 mV下用差分脉冲伏安法定量杂交双链DNA。利用FND进行电化学杂交,可以快速区分LPL基因的Wt (818G)/Wt (818G)纯合子、Wt (818G)/Mt (818A)杂合子和Mt (818A)/Mt (818A)纯合子。Wt (916g)和Mt (919G-del)等位基因的区分结果相同。该方法同样适用于其他LPL基因突变的检测。
英文摘要
Subjects (carriers) with heterozygous LPL deficiency are prone to develop mild hypertriglyceridemia (type IV hyperlipoproteinemia) when complicated with environmental factors such as a hyperinsulinemic state and/or a high alcohol intake, which stimulate triglyceride synthesis in the liver, while carriers are normolipidemic provided that they do not have the environmental factors. Identification of heterozygous LPL gene mutations as an early diagnosis, therefore, is important for preventing the development of hypertriglyceridemia and subsequent development of atherosclerosis by getting the patient to change to a more healthful lifestyle. We aimed to develop and evaluate an electrochemical hybridization assay with ferrocenylnaphthalene diimide (FND) for the detection of heterozygous LPL gene mutations.We developed the electrochemical hybridization assay for the detection of heterozygous LPL mutations, which are heterozygotes for a G-to-A transition at the 818th position (G188E : 818G normal allele and 818A mutant allele) and for a deletion of G at the 916th of the LPL gene-exon 5 (916G normal allele and 916G-del mutant allele). Discriminating between a wild type (Wt) allele and mutant type (Mt) allele is based on the hybridization between two probes such as a Wt probe and a Mt probe (13-15 mer) immobilized on a gold electrode and the PCR product od exon 5 (350 bp). The hybridized double-stranded DNA was quantified by a differential pulse voltammetry at 460 mV using FND as an intercalator.The electrochemical hybridization assay with FND allowed quick discrimination among a Wt (818G)/Wt (818G) homozygote, a Wt (818G)/Mt (818A) heterozygote and a Mt (818A)/Mt (818A) homozygote of the LPL gene. The same results were obtained for the discrimination of a Wt (916g) allele and a Mt (919G-del) allele. This method is also applicable for the detection of other LPL gene mutations.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
高木 敦子: "高カイロミクロン血症患者からの新しいリポ蛋白リパーゼ(LPL)遺伝子異常-複合型ヘテロ接合体の検出-"The Lipid. 13. 102-109 (2002)
Atsuko Takagi:“来自高乳糜微粒血症患者的新脂蛋白脂肪酶 (LPL) 基因异常 - 复合杂合子的检测 -”The Lipid。 13. 102-109 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Ikeda: "A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency"Clinica Chimica Acta. 316. 179-185 (2002)
Y.Ikeda:“杂合脂蛋白脂肪酶缺乏症中高胰岛素血症和高甘油三酯血症的家庭研究”《临床化学学报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Ikeda: "Clinical features and genetic analysis of autosomal recessive hypercholesterolemia"J.Clin.Endocrinol.Metab.. 88. 2541-2547 (2003)
Y.Ikeda:“常染色体隐性高胆固醇血症的临床特征和遗传分析”J.Clin.Endocrinol.Metab.. 88. 2541-2547 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Yamashita: "Ferrocenylnaphthalene diimide-based electrochemical hybridization assay for a heterozygous deficiency of the lipoprotein lipase gene."Bioconjugate Chem.. 13. 1193-1199 (2002)
K.Yamashita:“基于二茂铁萘二酰亚胺的电化学杂交测定脂蛋白脂肪酶基因的杂合缺陷。”Bioconjugate Chem.. 13. 1193-1199 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    動脈硬化性疾患の発症に直結する新規バイオマーカーの発見と早期診断・治療法の開発
    Establishment of genetic diagnostics, preventive and development of treatment for atherogenic hypertriglyceridemia
    Development and application of DNA tip for the diagnosis of atherogenic hypertriglyceridemia
    Molecular biological studies on the formation of atherogenic small dense low density lipoprotein (sLDL)
    海外基金